Knee osteoarthritis
Conditions
Interventions
Experimental Group:The combination of long round needles and moxibustion
Control group 1:Long round needle
Sponsors
People's Liberation Army Logistics Support Force 962nd Hospital
Eligibility
Sex/Gender
All
Age
50 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Combined traditional Chinese and Western medicine diagnosis for KOA; 2. Kellgren-Lawrence grading scale II-III; 3. Aged between 50 and 75 years; 4. Have not undergone pain-relieving treatment in the past two weeks; 5. Stable vital signs and able to cooperate with and complete the clinical treatment; 6. Patients who can accept long filiform needles and moxibustion therapy; 7. Patients who have signed the informed consent form and are willing to accept follow-up.
Exclusion criteria
Exclusion criteria: 1 Those who do not meet the diagnostic criteria for knee osteoarthritis or do not conform to the traditional Chinese medicine (TCM) syndrome differentiation standard for "meridian-sinew obstruction" (Bi syndrome). 2 Patients with secondary knee osteoarthritis, including but not limited to: rheumatoid arthritis, gouty arthritis, ankylosing spondylitis, infectious arthritis, post-traumatic arthritis, psoriatic arthritis, and tuberculous arthritis. 3 Those complicated by other knee joint diseases, such as knee joint tumors, pigmented villonodular synovitis (PVNS), suppurative arthritis, and tuberculous arthritis of the knee. 4 Patients with severe knee joint deformity (varus/valgus deformity > 15°), joint ankylosis, fibrous ankylosis, or knee instability where surgical intervention is indicated. 5 Patients with skin infections, ulcers, eczema, deep abscesses, or severe scarring around the knee joint that would make it unsafe to perform elongated needle procedures. 6 Patients with significant vascular pathology in the knee area (e.g., severe varicose veins, thrombophlebitis), a large popliteal cyst compressing blood vessels or nerves, or those whose muscle meridian (Jin) lesions cannot be clearly located due to extreme thinness or severe joint effusion, making the procedure unsafe. 7 Patients whose imaging examinations reveal intra-articular loose bodies that frequently cause joint locking, or a bucket-handle meniscal tear that mechanically obstructs joint movement. 8 Patients with coagulation disorders (e.g., hemophilia, thrombocytopenia), or those taking anticoagulant medications (e.g., warfarin, clopidogrel, aspirin) who have not completed the required washout period (typically 5-7 days) before the procedure. 9 Patients with severe primary diseases of the cardiovascular, cerebrovascular, hepatic, renal, pulmonary, or hematopoietic systems, or with malignant tumors or mental disorders, as well as patients with unstable hypertension or diabetes mellitus. 10 Women who are pregnant, lactating, or planning to become pregnant in the near future. 11 Patients with allergic constitutions, including severe allergy to moxa smoke or allergy to metal needles. 12 Patients with a keloid-forming tendency (keloid constitution).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS);Western Ontario and McMaster Universities Arthritis Index (WOMAC);Measure knee range of motion (KROM).;Musculoskeletal Ultrasound Record of the Knee Joint; | — |
Countries
China
Contacts
Public ContactDeng Weizhe
People's Liberation Army Logistics Support Force 962nd Hospital
Outcome results
None listed